Linda A. Adreveno

Corporate Officer/Principal en Society Of Human Resources Management .

68 años

Health Technology

Consumer Services

Perfil

Linda A.
Adreveno currently works at Society Of Human Resources Management, as Member.
Ms. Adreveno also formerly worked at Nektar Therapeutics, as Senior Director-Human Resources from 2001 to 2006, MannKind Corp., as Senior Vice President-Human Resources, and Neos Therapeutics, Inc., as Vice President-Human Resources.
Ms. Adreveno received her undergraduate degree from Excelsior College (New York) and graduate degree from John F.
Kennedy University.

Cargos activos de Linda A. Adreveno

Empresas	Cargo	Inicio
Society Of Human Resources Management	Corporate Officer/Principal	-

Todos los cargos activos de Linda A. Adreveno

Antiguos cargos conocidos de Linda A. Adreveno.

Empresas	Cargo	Fin
NEKTAR THERAPEUTICS	Oficial de Recursos Humanos	01/01/2006
NEOS THERAPEUTICS, INC.	Oficial de Recursos Humanos	-
MANNKIND CORPORATION	Oficial de Recursos Humanos	-

Ver el detalle de la experiencia de Linda A. Adreveno.

Formación de Linda A. Adreveno.

Excelsior College (New York)	Undergraduate Degree
John F. Kennedy University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Linda A. Adreveno.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
MANNKIND CORPORATION	Health Technology
NEKTAR THERAPEUTICS	Health Technology

Empresas privadas	2
Society Of Human Resources Management
Neos Therapeutics, Inc. Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.	Health Technology